Smita Gupta, MD
Endocrinology · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Gupta’s office at (408) 227-2646 to ask if they take your plan before you enroll.
California Medical Board record
Licence C134136 · Current
Licensed to practise in California · since 2015 · expires 2028-09-30 · University of Rajasthan, Sardar Patel Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$309,334
Medicare paid this office $309,334 for 575 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 392 | $88,959 | $111 |
| Injection, romosozumab-aqqg, 1 mg | 11 | $76,497 | None |
| Injection, denosumab, 1 mg | 39 | $71,657 | None |
| New patient visit (45+ min) | 139 | $20,414 | $147 |
| Long return visit (40+ min) | 61 | $13,762 | $164 |
See all 15 services
| Return visit (30+ min) | 392 | $88,959 | $111 |
| Injection, romosozumab-aqqg, 1 mg | 11 | $76,497 | None |
| Injection, denosumab, 1 mg | 39 | $71,657 | None |
| New patient visit (45+ min) | 139 | $20,414 | $147 |
| Long return visit (40+ min) | 61 | $13,762 | $164 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 406 | $9,480 | $14 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 103 | $8,242 | $30 |
| Short return visit (20+ min) | 63 | $5,979 | $81 |
| New patient visit (60+ min) | 17 | $3,194 | $188 |
| Ultrasound scan of head and neck soft tissue | 27 | $2,576 | $95 |
| Injection of drug or substance under skin or into muscle | 50 | $2,090 | $14 |
| New patient visit (30+ min) | 19 | $1,712 | $90 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 13 | $1,469 | $113 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,114 | $70 |
| Hemoglobin a1c level | 69 | $874 | $10 |
Who their Medicare patients are
575 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 13% · Women 66% · Also on Medicaid 14% · Health risk score 1.35. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 53% · Coronary heart disease 31% · Chronic kidney disease 30% · Cancer 22% · Heart failure 17% · Atrial fibrillation 15% · Depression 15% · COPD 10% · Stroke 9% · Dementia 7%.
The office billed $1,389,967, Medicare allowed $406,748 and paid $309,334; for 19,838 services of 22 kinds; $148,403 of it was for drugs given in the office and $160,930 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 575 | 19,838 | 75 | 1.35 | $1,389,967 | $309,334 |
| 2023 | 487 | 11,233 | 75 | 1.30 | $822,260 | $193,376 |
| 2022 | 232 | 2,071 | 74 | 1.24 | $161,790 | $43,326 |
| 2015 | 304 | 743 | 66 | 1.85 | $82,378 | $39,678 |
| 2014 | 312 | 809 | 66 | 1.60 | $95,671 | $49,227 |
| 2013 | 309 | 740 | 65 | 1.56 | $99,984 | $50,978 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 323 | $76,596 | $109 |
| Injection, denosumab, 1 mg | 22 | $33,227 | None |
| New patient visit (45+ min) | 148 | $21,629 | $146 |
| Long return visit (40+ min) | 35 | $5,948 | $157 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 57 | $4,074 | $31 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 26 | $3,395 | $126 |
| New patient visit (30+ min) | 34 | $3,080 | $91 |
| New patient visit (60+ min) | 16 | $3,080 | $192 |
| Short return visit (20+ min) | 40 | $3,061 | $73 |
| Ultrasound scan of head and neck soft tissue | 25 | $2,451 | $98 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,587 | $113 |
| Injection of drug or substance under skin or into muscle | 29 | $1,265 | $14 |
| Hemoglobin a1c level | 60 | $865 | $10 |
2022: 8 services
| Return visit (30+ min) | 148 | $19,047 | $118 |
| Long return visit (40+ min) | 22 | $3,937 | $171 |
| New patient visit (45+ min) | 19 | $2,831 | $149 |
| Short return visit (20+ min) | 25 | $2,114 | $85 |
| Influenza vaccine split virus, preservative free | 19 | $1,302 | $69 |
| Administration of influenza virus vaccine | 20 | $745 | $37 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 17 | $635 | $32 |
| Hemoglobin a1c level | 42 | $409 | $10 |
2015: 8 services
| Return visit (30+ min) | 174 | $21,430 | $68 |
| New patient visit (45+ min) | 49 | $4,758 | $97 |
| Short return visit (20+ min) | 69 | $3,578 | $45 |
| Hemoglobin a1c level | 123 | $2,426 | $13 |
| New patient visit (30+ min) | 32 | $2,177 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,761 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,586 | $99 |
| Ultrasound scan of head and neck soft tissue | 12 | $848 | $71 |
2014: 7 services
| Return visit (30+ min) | 187 | $26,293 | $72 |
| New patient visit (45+ min) | 85 | $9,823 | $116 |
| Short return visit (20+ min) | 71 | $4,205 | $47 |
| New patient visit (30+ min) | 34 | $2,565 | $75 |
| Hemoglobin a1c level | 108 | $2,286 | $13 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,145 | $104 |
| Ultrasound scan of head and neck soft tissue | 13 | $1,105 | $85 |
2013: 7 services
| Return visit (30+ min) | 165 | $23,705 | $72 |
| New patient visit (45+ min) | 126 | $13,493 | $107 |
| Short return visit (20+ min) | 73 | $4,983 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,962 | $53 |
| New patient visit (30+ min) | 27 | $1,776 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,178 | $98 |
| Hemoglobin a1c level | 63 | $1,009 | $13 |
Drugs they prescribed that Part D paid
$2,029,782
Pharmacies billed $2,029,782 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,771) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
1,612 generic and 1,910 brand-name prescriptions · $2,029,782 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 239 | $398,569 | $1,668 |
| Jardiance | 211 | $315,135 | $1,494 |
| Mounjaro | 102 | $168,095 | $1,648 |
| Farxiga | 117 | $158,989 | $1,359 |
| Trulicity | 100 | $157,613 | $1,576 |
See all 55 drugs
| Ozempic | 239 | $398,569 | $1,668 |
| Jardiance | 211 | $315,135 | $1,494 |
| Mounjaro | 102 | $168,095 | $1,648 |
| Farxiga | 117 | $158,989 | $1,359 |
| Trulicity | 100 | $157,613 | $1,576 |
| Januvia | 85 | $96,673 | $1,137 |
| Rybelsus | 49 | $76,363 | $1,558 |
| Tresiba Flextouch U-200 | 45 | $65,727 | $1,461 |
| Tymlos | 17 | $53,444 | $3,144 |
| Toujeo Solostar | 60 | $44,421 | $740 |
| Toujeo Max Solostar | 20 | $41,389 | $2,069 |
| Fiasp Flextouch | 32 | $40,041 | $1,251 |
| Tradjenta | 27 | $38,273 | $1,418 |
| Lyumjev Kwikpen U-100 | 34 | $35,015 | $1,030 |
| Tresiba Flextouch U-100 | 50 | $30,582 | $612 |
| Humalog Kwikpen U-100 | 53 | $24,707 | $466 |
| Synthroid | 197 | $21,534 | $109 |
| Novolog Flexpen | 61 | $19,933 | $327 |
| Vascepa | 15 | $13,373 | $892 |
| Lantus Solostar | 107 | $13,185 | $123 |
| Nano 2nd Gen Pen Needle | 108 | $12,097 | $112 |
| Cinacalcet | 17 | $6,822 | $401 |
| Basaglar Kwikpen U-100 | 14 | $5,921 | $423 |
| Ultra-Fine Mini Pen Needle | 38 | $5,051 | $133 |
| Novolog | 12 | $4,314 | $359 |
| Levothyroxine | 307 | $3,351 | $11 |
| Ultra-Fine Short Pen Needle | 26 | $3,221 | $124 |
| Insulin Lispro Kwikpen U-100 | 12 | $2,764 | $230 |
| Ultra-Fine Nano Pen Needle | 26 | $2,335 | $90 |
| Hydrocortisone | 29 | $2,012 | $69 |
| Metformin Hcl Er | 172 | $2,007 | $12 |
| Repaglinide | 47 | $1,830 | $39 |
| Testosterone | 14 | $1,730 | $124 |
| Metformin | 180 | $1,420 | $8 |
| Ezetimibe | 40 | $1,177 | $29 |
| Atorvastatin | 124 | $1,033 | $8 |
| Droplet Pen Needle | 15 | $966 | $64 |
| Nateglinide | 12 | $855 | $71 |
| Rosuvastatin | 53 | $794 | $15 |
| Glipizide | 50 | $790 | $16 |
| Glimepiride | 106 | $738 | $7 |
| Pioglitazone | 50 | $714 | $14 |
| Losartan | 65 | $577 | $9 |
| Alendronate | 87 | $573 | $7 |
| Gabapentin | 19 | $555 | $29 |
| Methimazole | 25 | $334 | $13 |
| Pravastatin | 20 | $299 | $15 |
| Glipizide Er | 21 | $240 | $11 |
| Losartan-Hydrochlorothiazide | 11 | $237 | $22 |
| Fenofibrate | 16 | $193 | $12 |
| Amlodipine Besylate | 32 | $139 | $4 |
| Lisinopril | 22 | $97 | $4 |
| Simvastatin | 15 | $45 | $3 |
| Lisinopril-Hydrochlorothiazide | 17 | $24 | $1 |
| Atenolol | 11 | $5 | $0 |
Year by year
| 2024 | 3,771 | 504 | 0% (0) | 51% | $2,029,782 |
| 2023 | 3,262 | 533 | 0% (0) | 51% | $2,028,905 |
| 2022 | 5,792 | 738 | 0% (0) | 54% | $3,707,262 |
| 2021 | 7,050 | 579 | 0% (0) | 54% | $4,151,614 |
| 2020 | 6,510 | 580 | 0% (0) | 53% | $3,554,895 |
| 2019 | 5,855 | 579 | 0% (0) | 49% | $2,586,521 |
| 2018 | 5,937 | 468 | 0% (0) | 47% | $1,936,929 |
| 2017 | 3,478 | 285 | None | 44% | $891,397 |
| 2016 | 2,538 | 375 | None | 43% | $656,171 |
| 2015 | 4,158 | 332 | 0% (0) | 45% | $1,307,366 |
| 2014 | 3,085 | 311 | None | 47% | $821,648 |
| 2013 | 2,040 | 239 | None | 50% | $412,940 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 52 drugs
| Trulicity | 139 | $292,967 | $2,108 |
| Jardiance | 206 | $282,614 | $1,372 |
| Ozempic | 107 | $189,118 | $1,767 |
| Farxiga | 166 | $177,928 | $1,072 |
| Novolog Flexpen | 88 | $116,047 | $1,319 |
| Rybelsus | 63 | $115,113 | $1,827 |
| Forteo | 22 | $96,683 | $4,395 |
| Januvia | 65 | $91,189 | $1,403 |
| Lantus Solostar | 98 | $84,296 | $860 |
| Humalog Kwikpen U-100 | 56 | $78,757 | $1,406 |
| Toujeo Solostar | 52 | $53,622 | $1,031 |
| Toujeo Max Solostar | 26 | $43,174 | $1,661 |
| Tresiba Flextouch U-200 | 34 | $42,435 | $1,248 |
| Invokana | 19 | $25,433 | $1,339 |
| Mounjaro | 20 | $24,336 | $1,217 |
| Fiasp Flextouch | 12 | $21,834 | $1,819 |
| Tradjenta | 13 | $21,266 | $1,636 |
| Lantus | 18 | $19,135 | $1,063 |
| Synthroid | 151 | $18,815 | $125 |
| Tresiba Flextouch U-100 | 35 | $18,373 | $525 |
| Vascepa | 13 | $11,120 | $855 |
| Insulin Aspart Flexpen | 11 | $8,211 | $746 |
| Nano 2nd Gen Pen Needle | 70 | $7,331 | $105 |
| Basaglar Kwikpen U-100 | 16 | $6,778 | $424 |
| Ultra-Fine Mini Pen Needle | 34 | $5,053 | $149 |
| Levothyroxine | 277 | $4,437 | $16 |
| Ultra-Fine Nano Pen Needle | 25 | $2,922 | $117 |
| Metformin | 208 | $2,644 | $13 |
| Metformin Hcl Er | 118 | $1,990 | $17 |
| Atorvastatin | 137 | $1,967 | $14 |
| Ultra-Fine Short Pen Needle | 15 | $1,747 | $116 |
| Nateglinide | 15 | $1,545 | $103 |
| Glimepiride | 102 | $1,436 | $14 |
| Hydrocortisone | 18 | $1,303 | $72 |
| Cabergoline | 12 | $1,276 | $106 |
| Losartan | 64 | $1,073 | $17 |
| Rosuvastatin | 45 | $1,001 | $22 |
| Repaglinide | 15 | $908 | $61 |
| Pioglitazone | 53 | $900 | $17 |
| Alendronate | 67 | $825 | $12 |
| Ezetimibe | 23 | $786 | $34 |
| Glipizide | 41 | $567 | $14 |
| Gabapentin | 20 | $430 | $22 |
| Glipizide Er | 20 | $378 | $19 |
| Lisinopril | 33 | $283 | $9 |
| Methimazole | 11 | $271 | $25 |
| Fenofibrate | 16 | $165 | $10 |
| Lisinopril-Hydrochlorothiazide | 16 | $120 | $8 |
| Simvastatin | 16 | $86 | $5 |
| Amlodipine Besylate | 15 | $74 | $5 |
| Atenolol | 12 | $28 | $2 |
| Dexamethasone | 14 | $11 | $1 |
2022: 58 drugs
| Trulicity | 460 | $802,965 | $1,746 |
| Jardiance | 457 | $494,907 | $1,083 |
| Farxiga | 284 | $312,951 | $1,102 |
| Ozempic | 182 | $296,134 | $1,627 |
| Novolog Flexpen | 195 | $234,348 | $1,202 |
| Invokana | 128 | $145,601 | $1,138 |
| Januvia | 124 | $136,177 | $1,098 |
| Rybelsus | 87 | $125,896 | $1,447 |
| Tradjenta | 112 | $122,778 | $1,096 |
| Humalog Kwikpen U-100 | 89 | $117,983 | $1,326 |
| Lantus Solostar | 118 | $72,002 | $610 |
| Toujeo Solostar | 110 | $65,993 | $600 |
| Tresiba Flextouch U-100 | 87 | $55,898 | $643 |
| Victoza 3-Pak | 27 | $54,232 | $2,009 |
| Prolia | 29 | $42,696 | $1,472 |
| Vascepa | 45 | $38,457 | $855 |
| Tresiba Flextouch U-200 | 31 | $34,864 | $1,125 |
| Evenity (2 Syringes) | 14 | $31,286 | $2,235 |
| Cinacalcet | 15 | $29,653 | $1,977 |
| Toujeo Max Solostar | 22 | $25,524 | $1,160 |
| Fiasp Flextouch | 19 | $19,174 | $1,009 |
| Nano 2nd Gen Pen Needle | 112 | $16,472 | $147 |
| Basaglar Kwikpen U-100 | 47 | $15,304 | $326 |
| Icosapent Ethyl | 21 | $12,747 | $607 |
| Nateglinide | 70 | $12,419 | $177 |
| Lantus | 19 | $10,300 | $542 |
| Insulin Lispro Kwikpen U-100 | 21 | $8,493 | $404 |
| Repaglinide | 76 | $8,109 | $107 |
| Levothyroxine | 319 | $7,480 | $23 |
| Comfort Ez Pen Needle | 38 | $7,105 | $187 |
| Synthroid | 46 | $5,768 | $125 |
| Metformin | 448 | $5,171 | $12 |
| Pioglitazone | 155 | $5,124 | $33 |
| Atorvastatin | 314 | $5,078 | $16 |
| Ultra-Fine Nano Pen Needle | 46 | $4,811 | $105 |
| Metformin Hcl Er | 157 | $3,489 | $22 |
| Rosuvastatin | 46 | $3,073 | $67 |
| Easy Comfort Pen Needles | 21 | $2,876 | $137 |
| Ezetimibe | 35 | $2,542 | $73 |
| Ulticare Pen Needle | 25 | $2,489 | $100 |
| Ultra-Fine Short Pen Needle | 14 | $2,363 | $169 |
| Hydrocortisone | 40 | $2,180 | $54 |
| Losartan | 88 | $1,425 | $16 |
| Gabapentin | 36 | $1,355 | $38 |
| Glipizide | 70 | $1,152 | $16 |
| Alcohol Pads | 13 | $1,086 | $84 |
| Glimepiride | 44 | $1,049 | $24 |
| Alendronate | 86 | $986 | $11 |
| Methimazole | 87 | $949 | $11 |
| Fenofibrate | 16 | $854 | $53 |
| Calcitriol | 20 | $788 | $39 |
| Amlodipine Besylate | 46 | $580 | $13 |
| Pravastatin | 22 | $552 | $25 |
| Simvastatin | 44 | $491 | $11 |
| Hydrochlorothiazide | 51 | $490 | $10 |
| Metoprolol | 15 | $379 | $25 |
| Lisinopril | 41 | $335 | $8 |
| Benazepril | 16 | $159 | $10 |
2021: 65 drugs
| Trulicity | 551 | $914,754 | $1,660 |
| Jardiance | 459 | $447,619 | $975 |
| Ozempic | 273 | $396,212 | $1,451 |
| Farxiga | 229 | $272,470 | $1,190 |
| Novolog Flexpen | 242 | $264,041 | $1,091 |
| Januvia | 194 | $193,733 | $999 |
| Invokana | 192 | $173,015 | $901 |
| Humalog Kwikpen U-100 | 153 | $168,418 | $1,101 |
| Tradjenta | 176 | $167,840 | $954 |
| Rybelsus | 86 | $135,789 | $1,579 |
| Lantus Solostar | 172 | $92,294 | $537 |
| Victoza 3-Pak | 47 | $84,077 | $1,789 |
| Tresiba Flextouch U-100 | 102 | $74,405 | $729 |
| Toujeo Solostar | 154 | $72,392 | $470 |
| Prolia | 39 | $51,810 | $1,328 |
| Cinacalcet | 38 | $43,015 | $1,132 |
| Bydureon Bcise | 23 | $38,999 | $1,696 |
| Basaglar Kwikpen U-100 | 105 | $36,112 | $344 |
| Vascepa | 39 | $35,406 | $908 |
| Tresiba Flextouch U-200 | 25 | $28,478 | $1,139 |
| Insulin Lispro Kwikpen U-100 | 42 | $27,468 | $654 |
| Toujeo Max Solostar | 16 | $26,258 | $1,641 |
| Admelog Solostar | 22 | $18,923 | $860 |
| Nano 2nd Gen Pen Needle | 146 | $18,763 | $129 |
| Nateglinide | 119 | $18,096 | $152 |
| Janumet | 13 | $15,259 | $1,174 |
| Novolog | 15 | $14,130 | $942 |
| Fiasp Flextouch | 17 | $11,362 | $668 |
| Icosapent Ethyl | 18 | $9,968 | $554 |
| Comfort Ez Pen Needle | 49 | $8,648 | $176 |
| Levothyroxine | 323 | $7,617 | $24 |
| Ultra-Fine Nano Pen Needle | 85 | $7,416 | $87 |
| Praluent | 13 | $6,983 | $537 |
| Repaglinide | 77 | $6,520 | $85 |
| Lantus | 16 | $5,998 | $375 |
| Atorvastatin | 368 | $5,658 | $15 |
| Easy Comfort Pen Needles | 36 | $5,522 | $153 |
| Metformin | 554 | $5,347 | $10 |
| Pioglitazone | 185 | $4,289 | $23 |
| Ezetimibe | 35 | $4,180 | $119 |
| Ulticare Pen Needle | 48 | $3,815 | $79 |
| Rosuvastatin | 57 | $3,463 | $61 |
| Hydrocortisone | 61 | $2,971 | $49 |
| Metformin Hcl Er | 176 | $2,878 | $16 |
| Synthroid | 24 | $2,849 | $119 |
| Gabapentin | 49 | $1,744 | $36 |
| Glipizide | 116 | $1,276 | $11 |
| Glimepiride | 53 | $1,266 | $24 |
| Calcitriol | 25 | $1,242 | $50 |
| Losartan | 80 | $1,154 | $14 |
| Alendronate | 101 | $1,086 | $11 |
| Ultracare Pen Needle | 24 | $1,003 | $42 |
| Methimazole | 91 | $898 | $10 |
| Fenofibrate | 22 | $813 | $37 |
| Amlodipine Besylate | 81 | $763 | $9 |
| Metoprolol | 21 | $404 | $19 |
| Hydrochlorothiazide | 48 | $403 | $8 |
| Pravastatin | 15 | $388 | $26 |
| Simvastatin | 48 | $366 | $8 |
| Lisinopril | 37 | $304 | $8 |
| Pentips | 11 | $285 | $26 |
| Olmesartan Medoxomil | 12 | $266 | $22 |
| Atenolol | 23 | $211 | $9 |
| Losartan-Hydrochlorothiazide | 13 | $200 | $15 |
| Benazepril | 21 | $177 | $8 |
2020: 62 drugs
| Trulicity | 498 | $793,563 | $1,594 |
| Jardiance | 303 | $311,243 | $1,027 |
| Novolog Flexpen | 245 | $305,004 | $1,245 |
| Januvia | 237 | $222,510 | $939 |
| Ozempic | 145 | $203,455 | $1,403 |
| Tradjenta | 218 | $187,723 | $861 |
| Farxiga | 155 | $179,870 | $1,160 |
| Invokana | 187 | $164,286 | $879 |
| Humalog Kwikpen U-100 | 116 | $149,641 | $1,290 |
| Lantus Solostar | 186 | $116,652 | $627 |
| Prolia | 72 | $92,513 | $1,285 |
| Victoza 3-Pak | 61 | $86,148 | $1,412 |
| Toujeo Solostar | 146 | $77,335 | $530 |
| Tresiba Flextouch U-100 | 75 | $62,289 | $831 |
| Bydureon Bcise | 45 | $53,601 | $1,191 |
| Forteo | 13 | $47,857 | $3,681 |
| Basaglar Kwikpen U-100 | 115 | $38,560 | $335 |
| Cinacalcet | 31 | $26,934 | $869 |
| Toujeo Max Solostar | 19 | $26,459 | $1,393 |
| Insulin Lispro Kwikpen U-100 | 42 | $23,886 | $569 |
| Vascepa | 27 | $21,573 | $799 |
| Ultra-Fine Nano Pen Needle | 187 | $20,068 | $107 |
| Novolog | 14 | $18,425 | $1,316 |
| Nateglinide | 102 | $13,787 | $135 |
| Admelog Solostar | 21 | $11,824 | $563 |
| Janumet | 12 | $11,246 | $937 |
| Levemir Flextouch | 15 | $10,409 | $694 |
| Invokamet Xr | 15 | $10,296 | $686 |
| Levothyroxine | 361 | $8,549 | $24 |
| Fiasp Flextouch | 11 | $7,444 | $677 |
| Ultracare Pen Needle | 54 | $6,248 | $116 |
| Repaglinide | 58 | $6,213 | $107 |
| Atorvastatin | 348 | $4,561 | $13 |
| Easy Comfort Pen Needles | 23 | $4,091 | $178 |
| Pioglitazone | 204 | $3,979 | $20 |
| Metformin | 503 | $3,950 | $8 |
| Nano 2nd Gen Pen Needle | 29 | $3,369 | $116 |
| Synthroid | 33 | $3,296 | $100 |
| Ulticare Pen Needle | 38 | $3,096 | $81 |
| Ezetimibe | 27 | $2,917 | $108 |
| Rosuvastatin | 46 | $2,674 | $58 |
| Metformin Hcl Er | 171 | $2,475 | $14 |
| Hydrocortisone | 53 | $1,965 | $37 |
| Alcohol Pads | 15 | $1,746 | $116 |
| Fenofibrate | 30 | $1,584 | $53 |
| Losartan | 102 | $1,282 | $13 |
| Glipizide | 130 | $1,199 | $9 |
| Methimazole | 75 | $1,055 | $14 |
| Alendronate | 78 | $638 | $8 |
| Amlodipine Besylate | 100 | $636 | $6 |
| Gabapentin | 51 | $608 | $12 |
| Glimepiride | 44 | $592 | $13 |
| Olmesartan Medoxomil | 11 | $534 | $49 |
| Calcitriol | 18 | $429 | $24 |
| Testosterone Cypionate | 12 | $392 | $33 |
| Metoprolol | 16 | $356 | $22 |
| Simvastatin | 54 | $262 | $5 |
| Hydrochlorothiazide | 50 | $221 | $4 |
| Benazepril | 12 | $142 | $12 |
| Pravastatin | 11 | $135 | $12 |
| Lisinopril | 28 | $126 | $4 |
| Atenolol | 18 | $103 | $6 |
2019: 67 drugs
| Trulicity | 312 | $418,422 | $1,341 |
| Januvia | 260 | $221,262 | $851 |
| Tradjenta | 266 | $218,804 | $823 |
| Novolog Flexpen | 191 | $200,626 | $1,050 |
| Humalog Kwikpen U-100 | 168 | $196,478 | $1,170 |
| Jardiance | 175 | $186,587 | $1,066 |
| Lantus Solostar | 194 | $116,745 | $602 |
| Farxiga | 107 | $115,124 | $1,076 |
| Toujeo Solostar | 141 | $77,721 | $551 |
| Prolia | 62 | $75,877 | $1,224 |
| Victoza 3-Pak | 63 | $74,905 | $1,189 |
| Invokana | 85 | $61,964 | $729 |
| Tresiba Flextouch U-100 | 69 | $51,010 | $739 |
| Bydureon Bcise | 38 | $47,764 | $1,257 |
| Ozempic | 28 | $43,272 | $1,545 |
| Basaglar Kwikpen U-100 | 90 | $28,844 | $320 |
| Sensipar | 14 | $25,887 | $1,849 |
| Tresiba Flextouch U-200 | 13 | $24,205 | $1,862 |
| Levemir Flextouch | 32 | $22,207 | $694 |
| Ultra-Fine Nano Pen Needle | 261 | $21,230 | $81 |
| Toujeo Max Solostar | 16 | $18,544 | $1,159 |
| Nateglinide | 91 | $15,059 | $165 |
| Victoza 2-Pak | 12 | $14,576 | $1,215 |
| Janumet | 12 | $12,758 | $1,063 |
| Cinacalcet | 14 | $12,183 | $870 |
| Admelog Solostar | 13 | $8,718 | $671 |
| Synjardy Xr | 11 | $8,315 | $756 |
| Bydureon | 12 | $8,088 | $674 |
| Novolog | 16 | $7,908 | $494 |
| Testosterone | 19 | $7,654 | $403 |
| Levothyroxine | 305 | $7,602 | $25 |
| Lantus | 24 | $7,365 | $307 |
| Easy Comfort Pen Needles | 55 | $6,860 | $125 |
| Pioglitazone | 247 | $4,999 | $20 |
| Janumet Xr | 11 | $4,508 | $410 |
| Ulticare Pen Needle | 67 | $4,108 | $61 |
| Atorvastatin | 253 | $3,624 | $14 |
| Metformin | 446 | $3,614 | $8 |
| Synthroid | 43 | $3,086 | $72 |
| Ultracare Pen Needle | 25 | $2,862 | $114 |
| Rosuvastatin | 54 | $2,499 | $46 |
| Comfort Ez Pen Needle | 22 | $2,375 | $108 |
| Metformin Hcl Er | 128 | $2,194 | $17 |
| Repaglinide | 26 | $1,930 | $74 |
| Hydrocortisone | 43 | $1,766 | $41 |
| Propylthiouracil | 11 | $1,707 | $155 |
| Gabapentin | 66 | $1,501 | $23 |
| Glimepiride | 62 | $1,334 | $22 |
| Glipizide | 141 | $1,260 | $9 |
| Easy Comfort Pen Needle | 13 | $1,075 | $83 |
| Alcohol Pads | 20 | $1,051 | $53 |
| Methimazole | 70 | $976 | $14 |
| Amlodipine Besylate | 128 | $972 | $8 |
| Ezetimibe | 13 | $959 | $74 |
| Losartan | 89 | $702 | $8 |
| Calcitriol | 16 | $602 | $38 |
| Metoprolol | 19 | $512 | $27 |
| Alendronate | 60 | $506 | $8 |
| Olmesartan Medoxomil | 11 | $496 | $45 |
| Glipizide Er | 26 | $400 | $15 |
| Simvastatin | 49 | $383 | $8 |
| Pravastatin | 12 | $303 | $25 |
| Lisinopril | 31 | $277 | $9 |
| Hydrochlorothiazide | 49 | $249 | $5 |
| Lisinopril-Hydrochlorothiazide | 16 | $128 | $8 |
| Lovastatin | 13 | $84 | $6 |
| Atenolol | 17 | $58 | $3 |
2018: 67 drugs
| Januvia | 353 | $204,361 | $579 |
| Tradjenta | 351 | $192,186 | $548 |
| Novolog Flexpen | 196 | $181,169 | $924 |
| Trulicity | 191 | $175,336 | $918 |
| Humalog Kwikpen U-100 | 163 | $136,450 | $837 |
| Lantus Solostar | 258 | $112,888 | $438 |
| Jardiance | 149 | $103,072 | $692 |
| Invokana | 118 | $83,643 | $709 |
| Forteo | 19 | $75,574 | $3,978 |
| Victoza 3-Pak | 62 | $67,133 | $1,083 |
| Toujeo Solostar | 133 | $64,789 | $487 |
| Farxiga | 77 | $49,341 | $641 |
| Prolia | 39 | $46,083 | $1,182 |
| Sensipar | 27 | $35,437 | $1,312 |
| Basaglar Kwikpen U-100 | 86 | $29,218 | $340 |
| Tresiba Flextouch U-100 | 40 | $25,269 | $632 |
| Bydureon | 20 | $20,302 | $1,015 |
| Tresiba Flextouch U-200 | 20 | $18,815 | $941 |
| Janumet | 33 | $17,924 | $543 |
| Bydureon Bcise | 16 | $17,497 | $1,094 |
| Ultra-Fine Nano Pen Needle | 270 | $16,769 | $62 |
| Apidra Solostar | 14 | $13,470 | $962 |
| Levemir Flextouch | 21 | $13,202 | $629 |
| Androgel | 12 | $10,774 | $898 |
| Novolog | 23 | $10,539 | $458 |
| Victoza 2-Pak | 11 | $10,031 | $912 |
| Nateglinide | 84 | $9,229 | $110 |
| Easy Comfort Pen Needles | 55 | $5,239 | $95 |
| Levothyroxine | 223 | $5,038 | $23 |
| Lantus | 12 | $4,665 | $389 |
| Atorvastatin | 288 | $4,335 | $15 |
| Metformin | 517 | $4,218 | $8 |
| Ulticare Pen Needle | 88 | $3,851 | $44 |
| Repaglinide | 42 | $2,932 | $70 |
| Pioglitazone | 174 | $2,775 | $16 |
| Glimepiride | 97 | $2,234 | $23 |
| Synthroid | 38 | $2,025 | $53 |
| Hydrocortisone | 49 | $2,012 | $41 |
| Metformin Hcl Er | 129 | $1,777 | $14 |
| Rosuvastatin | 46 | $1,718 | $37 |
| Gabapentin | 83 | $1,421 | $17 |
| Glipizide | 148 | $1,327 | $9 |
| Unifine Pentips | 33 | $1,251 | $38 |
| Easy Comfort Pen Needle | 16 | $1,249 | $78 |
| Losartan | 111 | $942 | $8 |
| Amlodipine Besylate | 101 | $917 | $9 |
| Metoprolol | 23 | $903 | $39 |
| Methimazole | 81 | $895 | $11 |
| Ultra-Fine Mini Pen Needle | 18 | $800 | $44 |
| Simvastatin | 78 | $600 | $8 |
| Sure Comfort | 15 | $473 | $32 |
| Easy Touch Pen Needle | 15 | $471 | $31 |
| Glipizide Er | 28 | $443 | $16 |
| Alendronate | 66 | $440 | $7 |
| Testosterone Cypionate | 17 | $383 | $23 |
| Lisinopril | 27 | $292 | $11 |
| Hydrochlorothiazide | 35 | $252 | $7 |
| Methylprednisolone | 15 | $208 | $14 |
| Lovastatin | 22 | $181 | $8 |
| Lisinopril-Hydrochlorothiazide | 20 | $157 | $8 |
| Furosemide | 31 | $148 | $5 |
| Topiramate | 13 | $117 | $9 |
| Benazepril | 17 | $117 | $7 |
| Losartan-Hydrochlorothiazide | 11 | $96 | $9 |
| Ranitidine | 14 | $95 | $7 |
| Carvedilol | 16 | $72 | $4 |
| Metoprolol | 11 | $51 | $5 |
2017: 53 drugs
| Novolog Flexpen | 140 | $116,527 | $832 |
| Januvia | 222 | $110,411 | $497 |
| Tradjenta | 186 | $92,376 | $497 |
| Lantus Solostar | 224 | $90,126 | $402 |
| Humalog Kwikpen U-100 | 112 | $86,080 | $769 |
| Forteo | 18 | $52,530 | $2,918 |
| Toujeo Solostar | 93 | $45,345 | $488 |
| Invokana | 74 | $35,006 | $473 |
| Prolia | 20 | $21,809 | $1,090 |
| Bydureon | 30 | $21,390 | $713 |
| Victoza 3-Pak | 22 | $18,254 | $830 |
| Jardiance | 35 | $17,432 | $498 |
| Trulicity | 20 | $16,992 | $850 |
| Levemir Flextouch | 22 | $14,291 | $650 |
| Farxiga | 21 | $13,208 | $629 |
| Tresiba Flextouch U-100 | 23 | $11,861 | $516 |
| Novolog | 21 | $11,348 | $540 |
| Ultra-Fine Nano Pen Needle | 164 | $8,322 | $51 |
| Lantus | 14 | $7,882 | $563 |
| Janumet | 12 | $4,718 | $393 |
| Nateglinide | 38 | $3,986 | $105 |
| Atorvastatin | 262 | $2,985 | $11 |
| Levothyroxine | 138 | $2,448 | $18 |
| Ulticare Pen Needle | 56 | $2,403 | $43 |
| Metformin | 284 | $1,959 | $7 |
| Easy Comfort Pen Needles | 26 | $1,756 | $68 |
| Repaglinide | 25 | $1,745 | $70 |
| Unifine Pentips | 52 | $1,686 | $32 |
| Glimepiride | 97 | $1,363 | $14 |
| Synthroid | 31 | $1,080 | $35 |
| Metformin Hcl Er | 115 | $1,001 | $9 |
| Sure Comfort | 27 | $976 | $36 |
| Pioglitazone | 55 | $936 | $17 |
| Ultra-Fine Mini Pen Needle | 20 | $899 | $45 |
| Rosuvastatin | 29 | $841 | $29 |
| Hydrocortisone | 15 | $799 | $53 |
| Losartan | 73 | $567 | $8 |
| Methylprednisolone | 11 | $467 | $42 |
| Methimazole | 45 | $447 | $10 |
| Metoprolol | 21 | $390 | $19 |
| Amlodipine Besylate | 71 | $372 | $5 |
| Alendronate | 54 | $367 | $7 |
| Glipizide | 65 | $294 | $5 |
| Simvastatin | 25 | $246 | $10 |
| Lovastatin | 25 | $219 | $9 |
| Gabapentin | 35 | $174 | $5 |
| Topiramate | 12 | $136 | $11 |
| Glipizide Er | 11 | $109 | $10 |
| Ranitidine | 12 | $84 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $79 | $7 |
| Hydrochlorothiazide | 14 | $76 | $5 |
| Metoprolol | 12 | $75 | $6 |
| Furosemide | 20 | $57 | $3 |
2016: 48 drugs
| Levemir Flextouch | 85 | $101,272 | $1,191 |
| Humalog Kwikpen U-100 | 110 | $86,334 | $785 |
| Lantus Solostar | 126 | $67,108 | $533 |
| Januvia | 128 | $56,039 | $438 |
| Novolog Flexpen | 71 | $55,356 | $780 |
| Victoza 3-Pak | 47 | $41,358 | $880 |
| Forteo | 14 | $34,961 | $2,497 |
| Tradjenta | 61 | $24,551 | $402 |
| Lantus | 36 | $24,016 | $667 |
| Novolog | 22 | $19,751 | $898 |
| Toujeo Solostar | 41 | $17,896 | $436 |
| Bd Ultra-Fine Pen Needle | 168 | $10,773 | $64 |
| Humalog | 18 | $9,787 | $544 |
| Crestor | 16 | $6,847 | $428 |
| Onglyza | 11 | $6,238 | $567 |
| Invokana | 12 | $4,707 | $392 |
| Synthroid | 97 | $3,396 | $35 |
| Levothyroxine | 187 | $2,762 | $15 |
| Nateglinide | 26 | $2,113 | $81 |
| Atorvastatin | 161 | $2,100 | $13 |
| Metformin Hcl Er | 110 | $1,431 | $13 |
| Valsartan | 16 | $1,071 | $67 |
| Repaglinide | 18 | $1,050 | $58 |
| Metformin | 108 | $770 | $7 |
| Ulticare Pen Needle | 18 | $743 | $41 |
| Hydrocortisone | 18 | $723 | $40 |
| Glimepiride | 75 | $670 | $9 |
| Metoprolol | 21 | $653 | $31 |
| Unifine Pentips | 18 | $622 | $35 |
| Insulin | 14 | $509 | $36 |
| Insulin | 15 | $465 | $31 |
| Sure Comfort | 15 | $465 | $31 |
| Methimazole | 35 | $401 | $11 |
| Amlodipine Besylate | 64 | $391 | $6 |
| Gabapentin | 38 | $359 | $9 |
| Pravastatin | 15 | $353 | $24 |
| Losartan | 33 | $342 | $10 |
| Insulin | 12 | $316 | $26 |
| Alendronate | 50 | $291 | $6 |
| Pioglitazone | 11 | $289 | $26 |
| Glipizide Er | 14 | $274 | $20 |
| Lisinopril | 34 | $184 | $5 |
| Hydrochlorothiazide | 18 | $178 | $10 |
| Glipizide | 26 | $118 | $5 |
| Clonidine | 13 | $100 | $8 |
| Lovastatin | 13 | $89 | $7 |
| Simvastatin | 12 | $43 | $4 |
| Furosemide | 11 | $27 | $2 |
2015: 57 drugs
| Levemir Flextouch | 180 | $183,459 | $1,019 |
| Novolog Flexpen | 134 | $138,879 | $1,036 |
| Victoza 3-Pak | 156 | $130,689 | $838 |
| Humalog Kwikpen U-100 | 145 | $126,795 | $874 |
| Lantus Solostar | 164 | $116,512 | $710 |
| Lantus | 98 | $100,208 | $1,023 |
| Levemir | 48 | $72,411 | $1,509 |
| Januvia | 108 | $52,415 | $485 |
| Novolog | 55 | $47,175 | $858 |
| Bydureon | 44 | $29,528 | $671 |
| Toujeo Solostar | 12 | $24,783 | $2,065 |
| Humulin R U-500 | 18 | $22,031 | $1,224 |
| Humalog | 28 | $18,194 | $650 |
| Apidra Solostar | 25 | $17,468 | $699 |
| Bd Ultra-Fine Pen Needle | 249 | $17,251 | $69 |
| Lyrica | 42 | $16,939 | $403 |
| Onglyza | 35 | $14,283 | $408 |
| Crestor | 36 | $13,049 | $362 |
| Tradjenta | 35 | $12,789 | $365 |
| Metformin Hcl Er | 258 | $9,191 | $36 |
| Invokana | 18 | $6,896 | $383 |
| Synthroid | 182 | $6,312 | $35 |
| Levothyroxine | 269 | $4,935 | $18 |
| Namenda Xr | 12 | $4,215 | $351 |
| Atorvastatin | 191 | $2,892 | $15 |
| Fenofibrate | 31 | $2,574 | $83 |
| Insulin | 55 | $2,491 | $45 |
| Metoprolol | 38 | $2,163 | $57 |
| Gabapentin | 121 | $1,961 | $16 |
| Valsartan | 23 | $1,956 | $85 |
| Hydrocortisone | 26 | $1,337 | $51 |
| Glimepiride | 121 | $1,274 | $11 |
| Methimazole | 91 | $1,108 | $12 |
| Metformin | 126 | $846 | $7 |
| Insulin | 34 | $819 | $24 |
| Testosterone Cypionate | 16 | $747 | $47 |
| Pioglitazone | 23 | $649 | $28 |
| Glipizide Er | 16 | $588 | $37 |
| Alendronate | 70 | $559 | $8 |
| Armour Thyroid | 20 | $534 | $27 |
| Losartan | 46 | $521 | $11 |
| Insulin | 13 | $500 | $38 |
| Pravastatin | 22 | $460 | $21 |
| Hydrochlorothiazide | 42 | $436 | $10 |
| Glipizide | 66 | $393 | $6 |
| Amlodipine Besylate | 67 | $392 | $6 |
| Fludrocortisone Acetate | 14 | $330 | $24 |
| Losartan-Hydrochlorothiazide | 14 | $235 | $17 |
| Lisinopril | 42 | $233 | $6 |
| Liothyronine | 12 | $222 | $19 |
| Clonidine | 33 | $186 | $6 |
| Prednisone | 20 | $182 | $9 |
| Furosemide | 45 | $129 | $3 |
| Atenolol | 19 | $116 | $6 |
| Lisinopril-Hydrochlorothiazide | 17 | $80 | $5 |
| Metoprolol | 13 | $74 | $6 |
| Simvastatin | 12 | $72 | $6 |
2014: 47 drugs
| Lantus | 109 | $104,305 | $957 |
| Humalog | 155 | $101,737 | $656 |
| Levemir | 70 | $84,610 | $1,209 |
| Levemir Flexpen | 108 | $79,386 | $735 |
| Victoza 3-Pak | 87 | $66,425 | $764 |
| Lantus Solostar | 120 | $59,597 | $497 |
| Novolog Flexpen | 78 | $51,911 | $666 |
| Novolog | 68 | $48,435 | $712 |
| Januvia | 100 | $39,250 | $393 |
| Levemir Flextouch | 26 | $19,578 | $753 |
| Apidra Solostar | 21 | $16,525 | $787 |
| Tradjenta | 39 | $11,619 | $298 |
| Bd Ultra-Fine Pen Needle | 152 | $9,158 | $60 |
| Metformin Hcl Er | 199 | $8,757 | $44 |
| Onglyza | 16 | $6,212 | $388 |
| Androgel | 15 | $6,000 | $400 |
| Synthroid | 154 | $5,776 | $38 |
| Lyrica | 13 | $5,549 | $427 |
| Crestor | 17 | $4,903 | $288 |
| Cabergoline | 13 | $4,818 | $371 |
| Levothyroxine | 216 | $3,037 | $14 |
| Fenofibrate | 24 | $2,403 | $100 |
| Diovan | 11 | $2,396 | $218 |
| Atorvastatin | 140 | $2,264 | $16 |
| Insulin | 42 | $1,933 | $46 |
| Pioglitazone | 37 | $1,487 | $40 |
| Methimazole | 86 | $1,185 | $14 |
| Gabapentin | 77 | $1,007 | $13 |
| Metformin | 102 | $912 | $9 |
| Glimepiride | 80 | $810 | $10 |
| Metoprolol | 23 | $797 | $35 |
| Amlodipine Besylate-Benazepril | 12 | $561 | $47 |
| Alendronate | 67 | $500 | $7 |
| Calcitriol | 17 | $455 | $27 |
| Insulin | 15 | $380 | $25 |
| Hydrochlorothiazide | 41 | $335 | $8 |
| Glipizide Er | 12 | $306 | $25 |
| Lisinopril | 57 | $303 | $5 |
| Amlodipine Besylate | 28 | $199 | $7 |
| Simvastatin | 20 | $183 | $9 |
| Glipizide | 35 | $177 | $5 |
| Furosemide | 35 | $145 | $4 |
| Losartan | 11 | $136 | $12 |
| Atenolol | 23 | $134 | $6 |
| Carvedilol | 13 | $113 | $9 |
| Lisinopril-Hydrochlorothiazide | 20 | $111 | $6 |
| Clonidine | 15 | $109 | $7 |
2013: 35 drugs
| Levemir Flexpen | 128 | $56,879 | $444 |
| Humalog | 96 | $41,697 | $434 |
| Novolog Flexpen | 85 | $41,613 | $490 |
| Lantus | 70 | $34,665 | $495 |
| Januvia | 85 | $30,523 | $359 |
| Lantus Solostar | 80 | $29,644 | $371 |
| Victoza 3-Pak | 30 | $21,623 | $721 |
| Levemir | 11 | $19,471 | $1,770 |
| Novolog | 31 | $15,324 | $494 |
| Apidra Solostar | 19 | $12,215 | $643 |
| Glumetza | 13 | $11,221 | $863 |
| Bd Ultra-Fine Pen Needle | 108 | $6,549 | $61 |
| Cabergoline | 11 | $6,008 | $546 |
| Metformin Hcl Er | 119 | $5,490 | $46 |
| Androgel | 14 | $5,303 | $379 |
| Synthroid | 151 | $4,749 | $31 |
| Fenofibrate | 16 | $3,009 | $188 |
| Crestor | 14 | $2,679 | $191 |
| Atorvastatin | 73 | $1,995 | $27 |
| Methimazole | 97 | $1,862 | $19 |
| Levothyroxine | 137 | $1,356 | $10 |
| Insulin | 35 | $1,309 | $37 |
| Metformin | 68 | $933 | $14 |
| Pioglitazone | 12 | $697 | $58 |
| Metoprolol | 21 | $684 | $33 |
| Gabapentin | 30 | $536 | $18 |
| Glimepiride | 60 | $517 | $9 |
| Alendronate | 43 | $378 | $9 |
| Lisinopril | 35 | $255 | $7 |
| Atenolol | 39 | $221 | $6 |
| Simvastatin | 15 | $164 | $11 |
| Amlodipine Besylate | 21 | $141 | $7 |
| Glipizide | 15 | $116 | $8 |
| Hydrochlorothiazide | 14 | $108 | $8 |
| Furosemide | 11 | $54 | $5 |
Money from drug and device companies
$190 in 2025
| 2025 | 2 | 13 | None | $190 |
| 2024 | 4 | 17 | None | $250 |
| 2023 | 3 | 17 | None | $229 |
| 2022 | 23 | 106 | None | $1,933 |
| 2021 | 30 | 263 | None | $4,178 |
| 2020 | 26 | 222 | None | $3,429 |
| 2019 | 25 | 229 | None | $2,987 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Benlysta | $173 | 12 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $17 | 1 payment
|
See all 13 published payments
| GlaxoSmithKline | Meals · 2025-12-02 | Benlysta | $15 |
| GlaxoSmithKline | Meals · 2025-11-04 | Benlysta | $14 |
| GlaxoSmithKline | Meals · 2025-10-14 | Benlysta | $14 |
| GlaxoSmithKline | Meals · 2025-09-29 | Benlysta | $14 |
| GlaxoSmithKline | Meals · 2025-08-19 | Benlysta | $14 |
| GlaxoSmithKline | Meals · 2025-07-08 | Benlysta | $14 |
| GlaxoSmithKline | Meals · 2025-06-03 | Benlysta | $15 |
| GlaxoSmithKline | Meals · 2025-05-12 | Benlysta | $15 |
| GlaxoSmithKline | Meals · 2025-04-21 | Benlysta | $15 |
| GlaxoSmithKline | Meals · 2025-03-25 | Benlysta | $15 |
| GlaxoSmithKline | Meals · 2025-02-18 | Benlysta | $15 |
| Abbott Laboratories | Meals · 2025-02-10 | Freestyle Libre 3 | $17 |
| GlaxoSmithKline | Meals · 2025-01-13 | Benlysta | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $250
| GlaxoSmithKline | Benlysta | $167 | 12 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $51 | 3 payments
|
| Amgen | Evenity | $17 | 1 payment
|
| Radius Health | Tymlos | $15 | 1 payment
|
2023: $229
| GlaxoSmithKline | Benlysta | $178 | 14 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $28 | 2 payments
|
| Pfizer | Somavert | $23 | 1 payment
|
2022: $1,933
| Novo Nordisk | Rybelsus | $297 | 19 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $185 | 9 payments
|
| Radius Health | Tymlos | $171 | 9 payments
|
| Aurinia Pharma U.S. | Lupkynis | $151 | 6 payments
|
| GlaxoSmithKline | Benlysta | $139 | 12 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $138 | 7 payments
|
| Lilly USA | Trulicity | $129 | 7 payments
|
| Amgen | Evenity | $114 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $101 | 5 payments
|
| IBSA Pharma | Tirosint | $78 | 4 payments
|
| Alexion Pharmaceuticals | Strensiq | $59 | 3 payments
|
| Merck Sharp & Dohme | Januvia | $55 | 3 payments
|
| Mannkind | Afrezza | $43 | 2 payments
|
| Pfizer | Prevnar 20 | $43 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $39 | 2 payments
|
| Janssen Biotech | Remicade | $37 | 3 payments
|
| Ucb | Cimzia | $32 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $31 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $23 | 1 payment
|
| Abbott Laboratories | Freestyle Libre | $21 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $18 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $15 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $14 | 1 payment
|
2021: $4,178
| Novo Nordisk | Ozempic | $701 | 60 payments
|
| Lilly USA | Trulicity | $379 | 19 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $308 | 17 payments
|
| Amgen | Evenity | $287 | 14 payments
|
| MannKind | Afrezza | $274 | 17 payments
|
| Corcept Therapeutics | Korlym | $252 | 12 payments
|
| Kowa Pharmaceuticals America | Livalo | $206 | 11 payments
|
| Radius Health | Tymlos | $202 | 16 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $164 | 9 payments
|
| Merck Sharp & Dohme | Januvia | $148 | 10 payments
|
| Amarin Pharma | Vascepa | $146 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $138 | 6 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $118 | 11 payments
|
| Janssen Biotech | Remicade | $103 | 5 payments
|
| AbbVie | Synthroid | $102 | 6 payments
|
| IBSA Pharma | Tirosint | $98 | 5 payments
|
| Ultragenyx Pharmaceutical | Crysvita | $96 | 6 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $72 | 3 payments
|
| Aurinia Pharma U.S. | Lupkynis | $71 | 3 payments
|
| Horizon Therapeutics plc | Tepezza | $59 | 3 payments
|
| Dexcom | Dexcom G6 Transmitter | $46 | 2 payments
|
| Abbott Laboratories | Freestyle Libre | $36 | 2 payments
|
| Zealand Pharma US | Zegalogue | $36 | 2 payments
|
| Medtronic | Minimed 670g System | $34 | 2 payments
|
| Recordati Rare Diseases Inc. | None | $25 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $20 | 1 payment
|
| GlaxoSmithKline | Benlysta | $18 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $16 | 1 payment
|
| ASCEND Therapeutics US | Binosto | $14 | 1 payment
|
| Amryt Pharma Holdings | Myalept | $13 | 1 payment
|
2020: $3,429
| Novo Nordisk | Ozempic | $563 | 55 payments
|
| Amgen | Evenity | $365 | 20 payments
|
| Lilly USA | Trulicity | $364 | 18 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $321 | 19 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $199 | 10 payments
|
| Mannkind | Afrezza | $184 | 10 payments
|
| Radius Health | Tymlos | $166 | 12 payments
|
| Merck Sharp & Dohme | Januvia | $157 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $138 | 9 payments
|
| Amarin Pharma | Vascepa | $130 | 8 payments
|
| Kowa Pharmaceuticals America | Livalo | $130 | 8 payments
|
| GlaxoSmithKline | Benlysta | $110 | 6 payments
|
| Corcept Therapeutics | Korlym | $109 | 6 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $75 | 4 payments
|
| AbbVie | Synthroid | $70 | 4 payments
|
| Janssen Biotech | Remicade | $51 | 3 payments
|
| IBSA Pharma | Tirosint | $45 | 3 payments
|
| Horizon Therapeutics plc | Tepezza | $41 | 3 payments
|
| Companion Medical | Inpen | $39 | 2 payments
|
| Medtronic MiniMed | Minimed 670g System | $39 | 3 payments
|
| Janssen Pharmaceuticals | Invokana | $37 | 2 payments
|
| Dexcom | Dexcom G6 Cgm System | $25 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $23 | 2 payments
|
| Genzyme | Kevzara | $18 | 1 payment
|
| Senseonics | Eversense | $18 | 1 payment
|
| LifeScan | Ot Verio Flex Starter Kit | $14 | 1 payment
|
2019: $2,987
| AstraZeneca Pharmaceuticals LP | Farxiga | $465 | 23 payments
|
| Novo Nordisk | Ozempic | $433 | 64 payments
|
| Lilly USA | Jardiance | $371 | 38 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $326 | 19 payments
|
| Amgen | Evenity | $233 | 13 payments
|
| Janssen Pharmaceuticals | Invokana | $207 | 11 payments
|
| Amarin Pharma | Vascepa | $188 | 15 payments
|
| Merck Sharp & Dohme | Januvia | $138 | 12 payments
|
| IBSA Pharma | Tirosint | $77 | 4 payments
|
| Medtronic MiniMed | Minimed 670g System | $64 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $54 | 3 payments
|
| Shire North American Group | Natpara (Parathyroid Hormone) | $53 | 3 payments
|
| Dexcom | Dexcom Cgm | $50 | 2 payments
|
| Regeneron Healthcare Solutions | Praluent | $48 | 3 payments
|
| AbbVie | Synthroid | $46 | 3 payments
|
| Companion Medical | Inpen | $35 | 2 payments
|
| Insulet | Omnipod | $33 | 2 payments
|
| Horizon Therapeutics plc | None | $29 | 2 payments
|
| Radius Health | Tymlos | $27 | 2 payments
|
| GlaxoSmithKline | Benlysta | $25 | 1 payment
|
| Corcept Therapeutics | Korlym | $23 | 2 payments
|
| Senseonics | Eversense | $18 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $17 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Orencia | $14 | 1 payment
|
| Antares Pharma | Xyosted | $11 | 1 payment
|
Professional record
- NPI
- 1740284249
- Licence
- CA C134136, IL 036-118, IN 01069530A, PA MD424951California C134136: Current · expires 2028-09-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- IL 036118898, IN 201021470
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
- Mailing address
- 50 E Hamilton Ave Ste 280, Campbell, CA, 95008
- NPI first listed
- 2005-06-13
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2690 S White Rd Ste 50, San Jose, CA, 95148